Morgenthaler Partners Vii Lp - Net Worth and Insider Trading
Morgenthaler Partners Vii Lp Net Worth
The estimated net worth of Morgenthaler Partners Vii Lp is at least $2 Million dollars as of 2024-11-13. Morgenthaler Partners Vii Lp is the 10% Owner of OncoMed Pharmaceuticals Inc and owns about 2,509,671 shares of OncoMed Pharmaceuticals Inc (OMED) stock worth over $2 Million. Morgenthaler Partners Vii Lp is also the 10% Owner of Molecular Templates Inc and owns about 2,295 shares of Molecular Templates Inc (MTEM) stock worth over $761. Details can be seen in Morgenthaler Partners Vii Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Morgenthaler Partners Vii Lp has not made any transactions after 2013-07-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Morgenthaler Partners Vii Lp
Morgenthaler Partners Vii Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Morgenthaler Partners Vii Lp owns 5 companies in total, including GlobeImmune Inc (GBIM) , OncoMed Pharmaceuticals Inc (OMED) , and IPC Healthcare Inc (IPCM) among others .
Click here to see the complete history of Morgenthaler Partners Vii Lp’s form 4 insider trades.
Insider Ownership Summary of Morgenthaler Partners Vii Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GBIM | GlobeImmune Inc | 2014-07-08 | 10 percent owner |
| OMED | OncoMed Pharmaceuticals Inc | 2013-07-23 | 10 percent owner |
| IPCM | IPC Healthcare Inc | 2008-07-21 | 10 percent owner |
 | | 2006-06-27 | 10 percent owner |
| | 2005-10-28 | 10 percent owner |
Morgenthaler Partners Vii Lp Latest Holdings Summary
Morgenthaler Partners Vii Lp currently owns a total of 2 stocks. Among these stocks, Morgenthaler Partners Vii Lp owns 2,509,671 shares of OncoMed Pharmaceuticals Inc (OMED) as of July 23, 2013, with a value of $2 Million and a weighting of 99.97%. Morgenthaler Partners Vii Lp also owns 2,295 shares of Molecular Templates Inc (MTEM) as of October 28, 2005, with a value of $761 and a weighting of 0.03%.
Latest Holdings of Morgenthaler Partners Vii Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OMED | OncoMed Pharmaceuticals Inc | 2013-07-23 | 2,509,671 | 0.89 | 2,233,607 |
| MTEM | Molecular Templates Inc | 2005-10-28 | 2,295 | 0.33 | 761 |
Holding Weightings of Morgenthaler Partners Vii Lp
Morgenthaler Partners Vii Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Morgenthaler Partners Vii Lp has made a total of 0 transactions in OncoMed Pharmaceuticals Inc (OMED) over the past 5 years. The most-recent trade in OncoMed Pharmaceuticals Inc is the acquisition of 70,588 shares on July 23, 2013, which cost Morgenthaler Partners Vii Lp around $1 Million.
According to the SEC Form 4 filings, Morgenthaler Partners Vii Lp has made a total of 0 transactions in Molecular Templates Inc (MTEM) over the past 5 years. The most-recent trade in Molecular Templates Inc is the sale of 37 shares on October 28, 2005, which brought Morgenthaler Partners Vii Lp around $364,074.
Insider Trading History of Morgenthaler Partners Vii Lp
- 1
Morgenthaler Partners Vii Lp Trading Performance
GuruFocus tracks the stock performance after each of Morgenthaler Partners Vii Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Morgenthaler Partners Vii Lp is -41.88%. GuruFocus also compares Morgenthaler Partners Vii Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Morgenthaler Partners Vii Lp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Morgenthaler Partners Vii Lp's insider trading performs compared to the benchmark.
Performance of Morgenthaler Partners Vii Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -36.99 | | | | | |
| Relative Return to S&P 500(%) | -35.28 | | | | | |
Morgenthaler Partners Vii Lp Ownership Network
Ownership Network List of Morgenthaler Partners Vii Lp
Ownership Network Relation of Morgenthaler Partners Vii Lp
Morgenthaler Partners Vii Lp Owned Company Details
What does GlobeImmune Inc do?
Who are the key executives at GlobeImmune Inc?
Morgenthaler Partners Vii Lp is the 10 percent owner of GlobeImmune Inc. Other key executives at GlobeImmune Inc include other: Former 10% Owner Healthcare Ventures Vii Lp , other: Former 10% Owner John W Littlechild , and other: Former 10% Owner James H Cavanaugh .
GlobeImmune Inc (GBIM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of GlobeImmune Inc (GBIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GlobeImmune Inc (GBIM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
GlobeImmune Inc (GBIM)'s detailed insider trading history can be found in Insider Trading Tracker table.
GlobeImmune Inc Insider Transactions
Morgenthaler Partners Vii Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Morgenthaler Partners Vii Lp. You might contact Morgenthaler Partners Vii Lp via mailing address: 50 Public Square, Suite 2700, Cleveland Oh 44113.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
